ESPR icon

Esperion Therapeutics
ESPR

Overview Fund Activity

150 hedge funds and large institutions have $1.21B invested in Esperion Therapeutics in 2017 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 54 increasing their positions, 45 reducing their positions, and 13 closing their positions.

Holders
150
Holders Change
+19
Holders Change %
+14.5%
% of All Funds
3.75%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.15%
New
33
Increased
54
Reduced
45
Closed
13
Calls
$23M
Puts
$42.8M
Net Calls
-$19.8M
Net Calls Change
+$53.8M

Top Buyers

1
MG
1
Meditor Group
Bermuda
$115M
2
BB
2
BB Biotech
Switzerland
$105M
3
PHS
3
PFM Health Sciences
California
$27.5M
4
PCM
4
Pentwater Capital Management
Florida
$112M
5
Caisse de Depot et Placement du Quebec (CDPQ)
5
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
$12.6M

Top Sellers

1
RCM
1
RA Capital Management
Massachusetts
$0
2
BC
2
Boxer Capital
California
$25.1M
3
State Street
3
State Street
Massachusetts
$63.2M
4
PC
4
Paulson & Co
New York
$0
5
DCM
5
Discovery Capital Management
Connecticut
$39.2M
Name Market Value Shares Shares
Change 		Shares
Change %
MG
1
Meditor Group
Bermuda
$115M 2,294,935 +1,728,935 +305%
PCM
2
Pentwater Capital Management
Florida
$112M 2,243,200 +255,200 +13%
BB
3
BB Biotech
Switzerland
$105M 2,097,964 +584,422 +39%
BlackRock
4
BlackRock
New York
$76.3M 1,521,674 +243,468 +19%
Fidelity Investments
5
Fidelity Investments
Massachusetts
$67.3M 1,342,888 +4,300 +0.3%
State Street
6
State Street
Massachusetts
$63.2M 1,260,414 -246,100 -16%
CS
7
Credit Suisse
Switzerland
$53.3M 1,064,038 -49,757 -4%
Vanguard Group
8
Vanguard Group
Pennsylvania
$44.1M 880,323 +124,099 +16%
AC
9
Aisling Capital
New York
$42M 837,125 – –
DCM
10
Discovery Capital Management
Connecticut
$39.2M 783,059 -182,000 -19%
PA
11
Pinnacle Associates
New York
$36M 717,813 -16,640 -2%
WA
12
Wasatch Advisors
Utah
$35.8M 713,404 -42,311 -6%
Northern Trust
13
Northern Trust
Illinois
$29M 577,917 +143,004 +33%
PHS
14
PFM Health Sciences
California
$27.5M 548,682 +334,702 +156%
BC
15
Boxer Capital
California
$25.1M 500,000 -500,000 -50%
Balyasny Asset Management
16
Balyasny Asset Management
Illinois
$19.7M 393,150 +192,667 +96%
RPAM
17
Rhenman & Partners Asset Management
Sweden
$15.6M 311,803 -51,544 -14%
PAMU
18
Pictet Asset Management (UK)
United Kingdom
$15.4M 306,455 +33,574 +12%
PCM
19
Peregrine Capital Management
Minnesota
$14.5M 290,027 -28,640 -9%
AH
20
Aviva Holdings
Bahamas
$14.5M 289,100 -51,000 -15%
Goldman Sachs
21
Goldman Sachs
New York
$13M 259,096 +9,485 +4%
Caisse de Depot et Placement du Quebec (CDPQ)
22
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
$12.6M 250,000 +250,000 New
Lord, Abbett & Co
23
Lord, Abbett & Co
New Jersey
$11.8M 235,889 +96,912 +70%
GH
24
GAM Holding
Switzerland
$11.3M 225,000 – –
BNP Paribas Financial Markets
25
BNP Paribas Financial Markets
France
$10.1M 201,476 +199,890 +12,603%
1
2 3 4 5